New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t
Oncology February 19,2024
Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t
Oncology February 19,2024
A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya
Oncology February 19,2024
A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya
Oncology February 19,2024
Endoscopy within six hours does not lower mortality in GI bleed

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri
Gastroenterology February 19,2024
Endoscopy within six hours does not lower mortality in GI bleed

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri
Gastroenterology February 19,2024
Opioids frequently prescribed to patients with cirrhosis

Opioids frequently prescribed to patients with cirrhosis

by Elana Gotkine HealthDay ReporterOpioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 inClinical
Gastroenterology February 19,2024
Opioids frequently prescribed to patients with cirrhosis

Opioids frequently prescribed to patients with cirrhosis

by Elana Gotkine HealthDay ReporterOpioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 inClinical
Gastroenterology February 19,2024
Risk for adverse events not increased after COVID-19 vaccine in IBD

Risk for adverse events not increased after COVID-19 vaccine in IBD

(HealthDay)—Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to a study published online May 25 i
Gastroenterology February 19,2024
Risk for adverse events not increased after COVID-19 vaccine in IBD

Risk for adverse events not increased after COVID-19 vaccine in IBD

(HealthDay)—Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to a study published online May 25 i
Gastroenterology February 19,2024
Bloodstream infections in preemies may originate from their gut microbiomes

Bloodstream infections in preemies may originate from their gut microbiomes

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainDangerous bacterial bloodstream infections in preemies may originate from the infants' gut microbiomes, according
Gastroenterology February 19,2024
Bloodstream infections in preemies may originate from their gut microbiomes

Bloodstream infections in preemies may originate from their gut microbiomes

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainDangerous bacterial bloodstream infections in preemies may originate from the infants' gut microbiomes, according
Gastroenterology February 19,2024
A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr
Oncology February 19,2024
A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr
Oncology February 19,2024
Response to COVID-19 vaccine positive in patients with IBD

Response to COVID-19 vaccine positive in patients with IBD

(HealthDay)—Inflammatory bowel disease (IBD) patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online Ap
Gastroenterology February 19,2024
Response to COVID-19 vaccine positive in patients with IBD

Response to COVID-19 vaccine positive in patients with IBD

(HealthDay)—Inflammatory bowel disease (IBD) patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online Ap
Gastroenterology February 19,2024
AI-powered ultrasound imaging that detects breast cancer

AI-powered ultrasound imaging that detects breast cancer

by Pohang University of Science & Technology (POSTECH)Research Image. Credit: POSTECHBreast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major ca
Oncology February 19,2024
AI-powered ultrasound imaging that detects breast cancer

AI-powered ultrasound imaging that detects breast cancer

by Pohang University of Science & Technology (POSTECH)Research Image. Credit: POSTECHBreast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major ca
Oncology February 19,2024
MRI index can predict postop recurrence in Crohn disease

MRI index can predict postop recurrence in Crohn disease

A magnetic resonance imaging (MRI) index has been developed and validated for predicting postoperative recurrence (POR) in Crohn disease (CD), according to a study published in the May issue ofC
Gastroenterology February 19,2024
MRI index can predict postop recurrence in Crohn disease

MRI index can predict postop recurrence in Crohn disease

A magnetic resonance imaging (MRI) index has been developed and validated for predicting postoperative recurrence (POR) in Crohn disease (CD), according to a study published in the May issue ofC
Gastroenterology February 19,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com